The US Food and Drug Administration has approved Erelzi (etanercept-szzs) from Sandoz, which is a biosimilar to Amgen's blockbuster Enbrel.
Erelzi is approved for all indications of the reference product.
The above article was sent to subscribers in Pharmacy Daily's issue from 31 Aug 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 31 Aug 16